| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/02/2006 | CN1812763A Nail restructuring compositions for topical application |
| 08/02/2006 | CN1810867A Prepn of sodium alginate/chitosan mixture gel |
| 08/02/2006 | CN1810253A Composition of water soluble Azithromycin salt |
| 08/02/2006 | CN1267479C Nano particles of poly-lactic acid or polyethyllactide propyllactide for packing plant extract and preparation |
| 08/02/2006 | CN1267154C Calcium supplementation to reduce prostate cancer risk |
| 08/02/2006 | CN1267152C Polythylene glycol-interferon alpha foreeze dried preparation |
| 08/02/2006 | CN1267150C Eye drops |
| 08/02/2006 | CN1267106C Simethicone/anhydrous calcium phosphate compositions |
| 08/02/2006 | CN1267089C Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 08/02/2006 | CN1267088C Injection temp-sensing type implanting prepns. |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/01/2006 | US7084261 formed by reacting a polypeptide with a capped N-(formylalkyl)polyoxyalkylenealkamide, used for inhibiting HIV infection |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084132 Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
| 08/01/2006 | US7084131 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition |
| 08/01/2006 | US7084121 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 08/01/2006 | US7084119 Fibroblast growth factor peptide fragments having deletions in the amino acid sequences, conjugates with ricin, diphtheria or saporin, and carrier mixtures, used as wound heling agents or antiproliferative agents |
| 08/01/2006 | US7084114 Mixtures of insulin drug-oligomer comprising polyalkylene glycol |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7084107 Methods for stabilizing liquid nutritional products and products so stabilized |
| 08/01/2006 | US7083959 Constructs size fractionated to homogeneity; does not elicit an immune response to said moieties but does directly compete with said antigen for receptors on an immunocompetent cell that recognizes said determinant. |
| 08/01/2006 | US7083936 In aqueous solution; narrow particle size distribution |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083806 Wound gels |
| 08/01/2006 | US7083805 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 08/01/2006 | US7083798 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions |
| 08/01/2006 | US7083784 Molecules with extended half-lives, compositions and uses thereof |
| 08/01/2006 | US7083781 Film forming polymers, methods of use, and devices and applications thereof |
| 08/01/2006 | US7083748 Method and apparatus for continuous particle production using supercritical fluid |
| 08/01/2006 | US7083572 Therapeutic delivery systems |
| 08/01/2006 | CA2375946C Pharmaceutical tablet and process for making thereof |
| 08/01/2006 | CA2274467C Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 08/01/2006 | CA2251194C Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| 08/01/2006 | CA2197867C Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 08/01/2006 | CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 08/01/2006 | CA2191855C Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 07/31/2006 | CA2493282A1 Method and composition for inhibiting cancer cell growth using urease and weakly basic anti-cancer compounds |
| 07/27/2006 | WO2006079099A2 Method of conjugating aminothiol containing molecules to a polymer |
| 07/27/2006 | WO2006078593A2 Direct compression formulation and process |
| 07/27/2006 | WO2006078282A2 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 07/27/2006 | WO2006078161A1 Binding compounds, immunogenic compounds and peptidomimetics |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006077856A1 Injection for mastitis |
| 07/27/2006 | WO2006077724A1 Cancer vaccine preparation |
| 07/27/2006 | WO2006077597A2 Novel neuroprotective compounds and uses thereof |
| 07/27/2006 | WO2006077456A1 Oral administration of therapeutic agent coupled to transporting agent |
| 07/27/2006 | WO2006077309A1 Injectable pharmaceutical composition containing a catecholamine and a peptidic hormone |
| 07/27/2006 | WO2006062581A3 Delivery of therapeutic rnai agents for treating restenosis |
| 07/27/2006 | WO2006056463A3 Method for the production of albumen conjugates with non-steroidal antirheumatic drugs (nsar) |
| 07/27/2006 | WO2006053006A9 Retinoid solutions and formulations made therefrom |
| 07/27/2006 | WO2006042857A3 Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 07/27/2006 | WO2006026458A8 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 07/27/2006 | WO2006020898A3 Methods of screening for inhibitors and compositions thereof for treating or preventing mycobacterium tuberculosis infection |
| 07/27/2006 | WO2006013203A3 Prodrugs activated by rna-dependent dna-polymerases |
| 07/27/2006 | WO2005117904A3 Phosphonate analogs of hiv integrase inhibitor compounds |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005110483A3 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 07/27/2006 | WO2005107705A3 Extended therapeutic effect ocular implant treatments |
| 07/27/2006 | WO2005082416A3 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 07/27/2006 | WO2005002516A9 Leukocyte internalized peptide-drug conjugates |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060167237 Derivatives of monosaccharides for drug discovery |
| 07/27/2006 | US20060167229 Biologically active peptide conjugates |
| 07/27/2006 | US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/27/2006 | US20060167218 Polyalkylene glycol acid additives |
| 07/27/2006 | US20060167116 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups |
| 07/27/2006 | US20060167095 Method for treating amyloidosis |
| 07/27/2006 | US20060167089 Method for inhibition or treatment of colon tumorigenesis |
| 07/27/2006 | US20060167073 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167071 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167064 Pharmaceutical liquid composition containing pyridone derivative |
| 07/27/2006 | US20060166953 Ciclesonide-containing sterile aqueous suspension |
| 07/27/2006 | US20060166938 Method of treatment using bisphosphonic acid |
| 07/27/2006 | US20060166931 Clathrates of butylphtualide with cyclodextrin or its derivatives, a process for their preparation and the use thereof |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166912 Use of cytochrome p450 enzyme cyp2w1 as a drug target for cancer theraphy |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166882 Liquid, aqueous pharmaceutical composition of Factor VII polypeptides |
| 07/27/2006 | US20060166871 Medical compositions containing ghrelin |
| 07/27/2006 | US20060166867 Argininamido-neomycin B conjugates; aminoglycoside antibiotics; for prevention and treatment of HIV infection |
| 07/27/2006 | US20060166862 Comprising a transcobalamin (TC) binding carrier and a therapeutic and/or diagnostic agent linked directly or through linker to the TC binding carrier; highly and efficiently absorbed |
| 07/27/2006 | US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/27/2006 | US20060165987 Stealthy polymeric biodegradable nanospheres and uses thereof |
| 07/27/2006 | US20060165826 Process for the preparation of antioxidant conserve from indian curry leaves (murraya koenigii spreng) |
| 07/27/2006 | US20060165823 Topical delivery agents and methods for making and using therm |
| 07/27/2006 | US20060165815 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 07/27/2006 | US20060165808 Microcapsules for the delayed, controlled release of perindopril |
| 07/27/2006 | US20060165807 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 07/27/2006 | US20060165804 Polymer compositions for administration to animals |
| 07/27/2006 | US20060165803 Pharmaceutical compositions of sertaconazole for vaginal use |
| 07/27/2006 | US20060165801 Hydrous gel and production process and use of the hydrous gel |
| 07/27/2006 | US20060165800 Short duration depot formulations |
| 07/27/2006 | US20060165793 Pharmaceutical preparation to be dispersed before administration |
| 07/27/2006 | US20060165792 Controlled release oxycodone compositions |
| 07/27/2006 | US20060165791 Oral dosage form prepared by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules; improving efficiency and quality of pain management |
| 07/27/2006 | US20060165781 Orally disintegrating tablets and process for obtaining them |
| 07/27/2006 | US20060165770 Lipid particles having asymmetric lipid coating and method of preparing same |
| 07/27/2006 | US20060165766 Liposomes encapsulate active agent; vehicles for the delivery of drugs and active agents as well as in the field of gene transfer; delayed, sustained or prolonged release, gradual release, timed release, pH dependent release |
| 07/27/2006 | US20060165763 Pasting agent |